All News

RFK Jr.'s testimony to Congress, broader access to peptides, and more health news from Morning Rounds…

Terremoto says that its AKT1 blockers can overcome toxicity challenges associated with PI3K/AKT inhibitors thr…

Nucleai has partnered with Sirona Dx to provide an integrated spatial proteomics solution for pharmaceutical a…

Boehringer Ingelheim and Zai Lab have entered into a clinical collaboration to investigate a dual DLL3-targeti…

Freya Biosciences is moving a microbial immunotherapy for IVF implantation failure into mid-stage trials after…

Abridge is partnering with top medical journals to bring in research for doctors to refer to during visits, pi…

The XBI is up 30% in six months, beating the S&P 500 by 24 percentage points — and the gap only widened in Apr…

This tracker provides data on global COVID-19 cases and deaths by country, region, and income-level. Additiona…

Equipped with $300 million, Beeline has an oral medicine for the treatment of lupus as well as other experimen…

Two new startups have begun testing their in vivo CAR-T therapies for autoimmune disease in people. China-base…

Inside Biogen's $5.6B buyout: CEO Chris Viehbacher has carried on with diversifying Biogen's business beyond i…

The FDA's guidance emphasises the potential of NGS methods to mitigate safety risks associated with therapies …

The protein is implicated in a wide swath of cancers, but harnessing it for drug R&D is still a major scie…

This brief highlights lessons from “Medicaid unwinding" that could help inform work requirement implementation…

Several of pharma’s top leaders scored large pay bumps last year, including two new chiefs who joined th…

Roche, AstraZeneca and Sanofi demonstrate how companies are following their own R&D paths.…

Informa Connect’s Life Sciences Pricing & Contracting USA May 18-20, 2026 | Philadelphia, PA Drug Channels rea…

This tracker examines Executive Actions taken by the Trump administration that have the potential to impact LG…

This brief provides on overview of funding proposals for domestic HIV programs and initiatives in President Tr…

Biotech IPOs gain long-lost momentum, and pharma companies find a way around the White House’s harsh tar…

With competition fierce in the weight loss space, a potential change to how the FDA classifies peptides could …

This week, I’m rerunning some popular posts while we prepare for today’s live video webinar: PBM Industry Upda…

False claims about the safety of mifepristone are driving legislative and investigative action in Congress, ev…